ClinicalTrials.gg

Alcon clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 719 studies whose lead sponsor is Alcon or one of 5 companies grouped under it. 9 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 12, 2026.

Our grouping of 5 registry names, not the registry’s. See them and correct one ↓

Compare Alcon with Glaukos and Huons Global →

Pipeline: 2 programs

Each counted once: 2 with a study Alcon leads registered in the last two years.

  • Phase 3
  • Phase 4 (approved, new studies)

The 1 phase-3 program — sign in to see them, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Alcon’s own registered studies; Alcon’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Alcon’s studies test, most studies first; none is open now — 44 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Show 20 more

The first 30 of 44; every drug is on its own page, and each page lists its sponsors.

Coming up

9 of Alcon’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 2N’26
  2. 1D
  3. 1J’27
  4. 1F
  5. M
  6. 1A
  7. 1M
  8. 1J
  9. 1J
  10. A
  11. S
  12. O
  13. N

Add all 9 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 18, 2026.

All 719 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now91%
  • Under way, not recruiting3<1%
  • Completed63889%
  • Stopped early6910%Terminated 42 · Withdrawn 27

Phase

Where

  • United States327
  • Canada25
  • United Kingdom22
  • Japan21
  • Australia20
  • Spain14

Over the years

  1. 07
  2. 08
  3. 09
  4. 7310
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 1226

By the year each study started; 77 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Alcon.

  • Alcon Research
    Subsidiary
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    624 studies →
  • CIBA VISION
    Acquired — became part of Alcon, Apr 8, 2011 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    52 studies →
  • Aerie Pharmaceuticals
    Acquired — became part of Alcon, Nov 21, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    36 studies →
  • Ivantis, Inc.
    Acquired — became part of Alcon, Jan 7, 2022 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    6 studies →
  • Alcon LenSx, Inc.
    Acquired — became part of Alcon, Aug 18, 2010 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Alcon leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 719. Browse all 719 →